473 related articles for article (PubMed ID: 16622600)
1. Strategies to improve plasma half life time of peptide and protein drugs.
Werle M; Bernkop-Schnürch A
Amino Acids; 2006 Jun; 30(4):351-67. PubMed ID: 16622600
[TBL] [Abstract][Full Text] [Related]
2. Rapid profiling of peptide stability in proteolytic environments.
Gorris HH; Bade S; Röckendorf N; Albers E; Schmidt MA; Fránek M; Frey A
Anal Chem; 2009 Feb; 81(4):1580-6. PubMed ID: 19159331
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic barriers for GI peptide and protein delivery.
Woodley JF
Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):61-95. PubMed ID: 7600588
[TBL] [Abstract][Full Text] [Related]
4. A new PEG-beta-alanine active derivative for releasable protein conjugation.
Pasut G; Mero A; Caboi F; Scaramuzza S; Sollai L; Veronese FM
Bioconjug Chem; 2008 Dec; 19(12):2427-31. PubMed ID: 19053302
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic barriers to peptide and protein absorption.
Lee VH
Crit Rev Ther Drug Carrier Syst; 1988; 5(2):69-97. PubMed ID: 3052875
[TBL] [Abstract][Full Text] [Related]
6. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
Seebach D; Beck AK; Bierbaum DJ
Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
[TBL] [Abstract][Full Text] [Related]
7. Optimization of Protein and Peptide Drugs Based on the Mechanisms of Kidney Clearance.
Wu H; Huang J
Protein Pept Lett; 2018; 25(6):514-521. PubMed ID: 29848260
[TBL] [Abstract][Full Text] [Related]
8. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
Bell SJ; Fam CM; Chlipala EA; Carlson SJ; Lee JI; Rosendahl MS; Doherty DH; Cox GN
Bioconjug Chem; 2008 Jan; 19(1):299-305. PubMed ID: 18020402
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate.
Amantana A; Moulton HM; Cate ML; Reddy MT; Whitehead T; Hassinger JN; Youngblood DS; Iversen PL
Bioconjug Chem; 2007; 18(4):1325-31. PubMed ID: 17583927
[TBL] [Abstract][Full Text] [Related]
10. Using spectrophotometry to determine in vitro turnover rates of peptides in plasma.
Fuglsang A; Nilsson D; Nyborg NC
J Biochem Biophys Methods; 2004 Feb; 58(2):139-51. PubMed ID: 14980787
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide and somatostatin releases correlated with the area under the lafutidine concentration-time curve in human plasma.
Ikawa K; Shimatani T; Azuma Y; Inoue M; Morikawa N
J Clin Pharm Ther; 2006 Aug; 31(4):351-6. PubMed ID: 16882104
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of a non-carbohydrate targeting platform for lysosomal proteins.
Stefano JE; Hou L; Honey D; Kyazike J; Park A; Zhou Q; Pan CQ; Edmunds T
J Control Release; 2009 Apr; 135(2):113-8. PubMed ID: 19146893
[TBL] [Abstract][Full Text] [Related]
13. Improving the therapeutic efficacy of peptides and proteins: a role for polysialic acids.
Gregoriadis G; Jain S; Papaioannou I; Laing P
Int J Pharm; 2005 Aug; 300(1-2):125-30. PubMed ID: 16046256
[TBL] [Abstract][Full Text] [Related]
14. Improving protein pharmacokinetics by engineering erythrocyte affinity.
Kontos S; Hubbell JA
Mol Pharm; 2010 Dec; 7(6):2141-7. PubMed ID: 20831257
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
Clin Pharmacol Ther; 2006 Nov; 80(5):502-8. PubMed ID: 17112806
[TBL] [Abstract][Full Text] [Related]
16. The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools.
De Buck SS; Sinha VK; Fenu LA; Gilissen RA; Mackie CE; Nijsen MJ
Drug Metab Dispos; 2007 Apr; 35(4):649-59. PubMed ID: 17267621
[TBL] [Abstract][Full Text] [Related]
17. The history of somatostatin analogs.
Pless J
J Endocrinol Invest; 2005; 28(11 Suppl International):1-4. PubMed ID: 16625837
[TBL] [Abstract][Full Text] [Related]
18. Protein turnover in growing cultures of Bacillus megaterium.
Chaloupka J; Strnadová M; Moravcová J
Acta Biol Med Ger; 1981; 40(10-11):1227-34. PubMed ID: 6805188
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.
De Buck SS; Sinha VK; Fenu LA; Nijsen MJ; Mackie CE; Gilissen RA
Drug Metab Dispos; 2007 Oct; 35(10):1766-80. PubMed ID: 17620347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
